| Cell lines |
classification |
PAI-1 MI [%] (M±SD) |
GSTPI MI [%] (M±SD) |
| HCAEC |
human coronary endothelium |
0.8 ± 0.4 |
0.0 ± 0.1 |
| HASMC |
human smooth muscle |
1.0 ± 0.1 |
0.0 ± 0.2 |
| PrEC |
human prostate epithelium |
1.5 ± 0.6 |
0.0 ± 0.1 |
| LNCaP |
human prostate adenocarcinoma |
78.5 ± 0.1 |
100.0 ± 1.6 |
| DU-145 |
human prostate cancer |
100.0 ± 21.0 |
52.1 ± 5.3 |
| PC-3 |
human prostate cancer |
7.0 ± 0.8 |
76.6 ± 4.5 |
| Jurkat |
human T cell leukemia |
1.4 ± 0.1 |
0.0 ± 0.1 |
| U-937 |
human monocytic leukemia |
9.1 ± 1.7 |
0.0 ± 0.3 |
| Raji |
human B cell leukemia |
31.0 ± 0.1 |
81.0 ± 7.0 |
| K-562 |
human CML in blast crisis |
26.5 ± 3.0 |
0.0 ± 0.2 |
| HepG2 |
human hepatocellular carcinoma |
1.3 ± 0.3 |
99.4 ± 19.3 |
| MCF-7 |
human mammary adenocarcinoma |
72.8 ± 5.6 |
98.9 ± 12.4 |
| A431 |
human epidermoid carcinoma |
2.6 ± 0.5 |
0.0 ± 0.1 |
| HeLa |
human cervical cancer |
2.2 ± 0.7 |
0.0 ± 0.3 |
